FSHR-mTOR-HIF1 signaling alleviates mouse follicles from AMPK-induced atresia

Cell Rep. 2023 Oct 31;42(10):113158. doi: 10.1016/j.celrep.2023.113158. Epub 2023 Sep 19.

Abstract

The majority of activated ovarian follicles undergo atresia during reproductive life in mammals, and only a small number of follicles are ovulated. Though hormone treatment has been widely used to promote folliculogenesis, the molecular mechanism behind follicle selection and atresia remains under debate due to inconsistency among investigation models. Using a high-throughput molecular pathology strategy, we depicted a transcriptional atlas of mouse follicular granulosa cells (GCs) under physiological condition and obtained molecular signatures in healthy and atresia GCs during development. Functional results revealed hypoxia-inducible factor 1 (HIF1) as a major effector downstream of follicle-stimulating hormone (FSH), and HIF1 activation is essential for follicle growth. Energy shortage leads to prevalent AMP-activated protein kinase (AMPK) activation and drives follicular atresia. FSHR-mTOR-HIF1 signaling helps follicles escape from the atresia fate, while energy stress persists. Our work provides a comprehensive understanding of the molecular network behind follicle selection and atresia under physiological condition.

Keywords: AMPK; CP: Developmental biology; HIF1; atresia; follicle selection; granulosa cells; mTOR.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases* / metabolism
  • Animals
  • Female
  • Follicular Atresia / physiology
  • Granulosa Cells* / metabolism
  • Hypoxia-Inducible Factor 1 / metabolism
  • Mammals
  • Mice
  • TOR Serine-Threonine Kinases / metabolism

Substances

  • AMP-Activated Protein Kinases
  • Hypoxia-Inducible Factor 1
  • TOR Serine-Threonine Kinases
  • mTOR protein, mouse